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Abstract
Background: The geographic distribution of environmental toxins is generally not uniform, with certain northern
regions showing a particularly high concentration of pesticides, heavy metals and persistent organic pollutants. For
instance, Northern Canadians are exposed to high levels of persistent organic pollutants like polychlorinated
biphenyls (PCB), organochlorine pesticides (OCs) and methylmercury (MeHg), primarily through country foods.
Previous studies have reported associations between neuronal pathology and exposure to such toxins. The present
investigation assessed whether perinatal exposure (gestation and lactation) of rats to a chemical mixture (27
constituents comprised of PCBs, OCs and MeHg) based on Arctic maternal exposure profiles at concentrations near
human exposure levels, would affect brain levels of several inflammatory cytokines
Methods: Rats were dosed during gestation and lactation and cytokine levels were measured in the brains of
offspring at five months of age. Hypothalamic cytokine protein levels were measured with a suspension-based
array system and differences were determined using ANOVA and post hoc statistical tests.
Results: The early life PCB treatment alone significantly elevated hypothalamic interleukin-6 (IL-6) levels in rats at
five months of age to a degree comparable to that of the entire chemical mixture. Similarly, the full mixture (and
to a lesser degree PCBs alone) elevated levels of the pro-inflammatory cytokine, IL-1b, as well as the anti-
inflammatory cytokine, IL-10. The full mixture of chemicals also moderately increased (in an additive fashion)
hypothalamic levels of the pro-inflammatory cytokines, IL-12 and tumor necrosis factor (TNF-a). Challenge with
bacterial endotoxin at adulthood generally increased hypothalamic levels to such a degree that differences
between the perinatally treated chemical groups were no longer detectable.
Conclusions: These data suggest that exposure at critical neurodevelopmental times to environmental chemicals
at concentrations and combinations reflective of those observed in vulnerable population can have enduring
consequences upon cytokines that are thought to contribute to a range of pathological states. In particular, such
protracted alterations in the cytokine balance within the hypothalamus would be expected to favor marked
changes in neuro-immune and hormonal communication that could have profound behavioral consequences.
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A wide array of substances found in the environment,
including metals (e.g. lead, iron, mercury), polychlori-
nated biphenyls (PCBs) and pesticides can be toxic to
the central nervous system (CNS). Sensitive sub-popula-
tions, such as the developing fetus, as well as elderly
individuals that are already at increased risk of illness
m a yb ee s p e c i a l l yv u l n e r a b l et ot h en e u r o l o g i c a le f f e c t s
of such toxins [1-4]. Indeed, considerable epidemiologi-
cal evidence indicates that prenatal or perinatal expo-
sure to PCBs, lead, and organochlorine pesticides (OCs)
can cause attention, memory and motor disturbances
later in life [5-11]. A number of epidemiological studies
have also demonstrated correlations between environ-
mental pollutants and neurodegenerative disease, such
as the increased incidence of Parkinson’s disease in rural
agricultural populations with high use of broad classes
of insecticides (e.g., rotenone), herbicides (e.g., paraquat)
and rodenticides [12-14].
Aboriginal people of northern Canada may be at
greater risk of health problems than other populations
because of higher levels of pollutants in the environment
and food chain, as well as their greater reliance on coun-
try food as part of their diet. Indeed, numerous studies
reported that high levels of heavy metals (particularly
MeHg), PCBs, and pesticides (e.g. DDT) bioaccumulate
in marine animals, fish and other wildlife [15-20]. These
findings are consistent with the fact that in several indi-
genous northern Canadian populations (Dene, Cree and
Inuit), maternal mercury and PCB levels were within the
range expected to increase the risk of neurological
damage and cause impairment of memory and executive
functioning in their offspring [21-23].
An important but often overlooked aspect of most
toxicological studies aimed at identifying health risks is
the fact that assessment of the effects of a single com-
pound can be misleading since individuals are typically
exposed to multiple pollutants over time. This is parti-
cularly important when one considers the substantial
evidence that environmental insults, such as pesticides,
can interact to additively or even synergistically provoke
neuronal damage [24-26]. To this end, we have begun
to conduct studies using a mixture of pollutants (as well
as the key individual constituents of the mixture; PCBs,
OCs, MeHg) based on the profile of chemicals actually
found in Arctic maternal Canadian populations. Gesta-
tional and lactational exposure to this Arctic chemical
mixture produced blood levels in rodents that were
comparable to those found in Inuit maternal blood and
induced a range of dose-dependent pathological changes
in offspring [27].
Although many cellular mechanisms likely contribute
to the neuropathological consequences of environmental
pollutants, recent evidence suggests a particular impor-
tance for neuroinflammatory factors [28,29]. For
instance, pro-inflammatory cytokines, as well as the
immunocompetent microglial cells, have been impli-
cated in several neurodegenerative diseases and were
reported to contribute to the neuronal damage induced
by pesticides, heavy metals and other potential toxins
[30-33]. Indeed, our own work has revealed that
enhanced microglia and cytokine activity was associated
with the neurodegenerative effects of the commonly
used pesticide, paraquat [30,34].
The present study sought to evaluate the alterations of
a panel of pro- and anti-inflammatory cytokines within
the hypothalamus of adult rats that previously received
in utero plus lactational exposure to the Arctic chemical
mixture (or individual constituents). Using a perinatal
exposure regimen is expected to mimic the “real life”
exposure pattern of the Arctic human population. It was
also of interest to determine whether perinatal exposure
to these chemical agents would augment the neuroin-
flammatory consequences following exposure to the bac-
terial endotoxin, lipopolysaccharide (LPS), later in
adulthood. Indeed, recent studies revealed that perinatal
exposure to LPS caused a long-term elevation of TNF-a
within the brain that was associated with an enhanced
neuronal susceptibility to subsequent pesticide exposure
in adulthood [35]. Cytokine protein levels were deter-
mined using a sensitive, laser based bead assay system
that allowed us to simultaneously assess multiple cyto-
kines. The hypothalamus was examined given the well
know endocrine effects of several toxins, as well as the
higher cytokine levels than most brain regions and sen-
sitivity to immune and stressor challenges [36,37]. Ulti-
mately, the combined prenatal chemical toxin exposure
followed by adult LPS challenge should be relevant to
the actual intermittent exposure to various classes of
toxins (immune, chemical, organic) at critical neurode-
velopmental and later times that likely occur in certain
vulnerable individuals.
Methods
Breeding conditions
Female offspring from nulliparous female Sprague Daw-
ley rats (Charles River Laboratories, St Constant, Que-
bec) were used in the present study. All animals were
housed in plastic hanging cages measuring 35 (L) × 30
(W) × 16.5 (H) cm with shaved wood bedding in hous-
ing rooms maintained at 22 ± 2°C and 50 ± 10% humid-
ity. Breeding was initiated three weeks after the animals
arrived in the facility and was conducted by placing two
females into each male cage and monitoring females
two times daily for vaginal plugs. Once a vaginal plug
was detected, the female was removed from the male
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vaginal plug was denoted as gestation Day 0 (GD0).
Beginning on gestation Day 18, dams were monitored
two times daily for parturition at 08:00 and 20:00. The
day of birth is denoted as postnatal Day (PND) 0. Pups
were sexed on PND 1 and gender confirmed on PND
2,3 and 4. Litters were culled to eight pups on PND 4
(four males and four females where possible) by ran-
domly selecting four males and four females from
each litter to remain in the litter. Male offspring were
assigned to a separate study and two female offspring
per litter were assigned to the present investigation. The
third female from each litter were assigned for histo-
pathological analysis to be reported separately.
Chemical administration procedures
Treatment procedures began on GD 1 and continued
until weaning at PND 21. Specifically, pregnant dams
received dosed small cookies (Teddy Graham cookies,
Nabisco Ltd., Toronto, ON) with a measured volume of
the appropriate dosing solution (1 ul/g body weight) in
corn oil. The dosing volume added to cookies was
adjusted daily based on the body weight that was col-
lected daily. This dosing method permits precise control
over dosing during gestation and lactation where food
or fluid intake can vary significant. Cages were checked
daily to verify that dams consumed the dosed cookies.
Importantly, using this procedure, offspring were never
dosed directly but rather received the toxins through
placental transfer during gestation and then from the
dams milk during perinatal lactation. Hence, the pups
receive indirect exposure to the toxin or vehicle dosed
cookies for a total of 42 days (21 days of gestation + 21
days of lactation).
Separate groups of pregnant females (N = 9-12) were
dosed with either corn oil vehicle, 0.05 mg/kg/day of the
full Arctic mixture, 0.01 mg/kg/day PCB, 0.02 mg/kg
MeHg, or 0.03 mg/kg/day PCB+MeHg (as shown in
Table 1) from GD1 to PND 21. The choice of combined
PCB+MeHg was used based on previously collected data
indicating that MeHg toxicity was attenuated in mixture
treated animals. (Bowers, unpublished observations)
This group permitted us to determine if the PCBs con-
tributed to the reduced MeHg toxicity in mixture-trea-
ted animals. Note that the doses of the mixture
components (e.g., PCBs only) were identical to the dose
contained in the complete Arctic mixture.
On PND 21, males and females were weaned and
housed in same sex groups of three in standard plastic
cages with ad libitum access to food and water. Male
offspring were assigned to a separate study and female
offspring were used in the present investigation. At
PND 65, female offspring were re-housed in pairs until
PND 145-147, when the animals were sacrificed by
decapitation. Brains were removed and the whole
hypothalamus was dissected using a rat brain matrix
[37,38] and frozen in liquid nitrogen and stored at -80°C
until processing.
On PND 208-212, a separate set of female litter-mates
were challenged with the bacterial endotoxin, lipopolysac-
charide (LPS; 48 ug/kg; i.p.) and 90 minutes later were
sacrificed by decapitation and the hypothalamus was dis-
sected and frozen for subsequent cytokine analysis
(see procedures below for dissection and assay details).
We have previously found that similar endotoxin doses
Table 1 Concentrations of individual chemicals in the
dosing solutions of Arctic mixture, the PCBs, and
methylmercury
Concentration (μg/ml)
Chemical Full
Mix
PCB
Alone
MeHg
Alone
PCB
+MeHg
PCBs 28 0.065 0.065 X 0.065
52 0.132 0.132 X 0.132
99 0.837 0.837 X 0.837
101 0.120 0.120 X 0.120
105 0.141 0.141 X 0.141
118 0.652 0.652 X 0.652
128 0.067 0.067 X 0.067
138 1.956 1.956 X 1.956
153 3.390 3.390 X 3.390
156 0.264 0.264 X 0. 264
170 0.541 0.541 X 0.541
180 1.379 1.379 X 1.379
183 0.167 0.167 X 0.167
187 0.687 0.687 X 0.687
OCs Aldrin 0.065 X X X
b-BHC 0.653 X X X
Cis-nonachlor 0.583 X X X
p,p’-DDE 9.075 X X X
p,p’-DDT 0.580 X X X
Dieldrin 0.264 X X X
Hexachlorobenzene 3.249 X X X
Heptachlor epoxide 0.273 X X X
Mirex 0.271 X X X
Oxychlordane 2.086 X X X
Toxaphene 1.20 X X X
Trans-nonachlor 2.367 X X X
MeHg 18.918 X 18.918 18.918
TOTAL PCB 10.397 10.397 X 10.397
TOTAL OCs 20.664 X X X
TOTAL all 49.979 10.397 18.918 29.316
The PCB+MeHg dosing solution contained only PCBs and MeHg. Pregnanat
females rats were dosed by applying 1 ul/g body weight on small cookies and
providing these to the pregnant dams.
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kine changes within hypothalamic and stressor-sensitive
limbic regions [36,39,40]. He n c e ,w es o u g h tt oa s s e s s
whether early life exposure to the Northern toxin consti-
tuents would enhance the neuroinflammatory cytokine
cascade that is provoked by LPS challenge. Indeed, this
situation should mimic instances where, individuals are
exposed to multiple environmental contaminants and
subsequently encounter typical infectious agents.
Mixture Preparation
The contaminant profile (relative concentrations) in
the mixture was based on the concentration of chemi-
cals found in maternal blood of Inuit population in
Arctic Canada [41]. Data on the concentration of the
chemicals in maternal blood of Inuit women were
obtained and the mean, geometric mean and median
concentration in μg/l blood (lipid adjusted) were calcu-
lated. Because most pollutants included were lipophilic
chemicals that are sensitive to variations in human
blood lipid levels, lipid-adjusted concentrations were
used in all calculations of relative contribution of lipo-
philic contaminants to the contaminant profile.
Methylmercury was excluded from these initial relative
mass concentrations because it is not lipophilic. The
contribution of MeHg to the mixture was based on the
MeHg: lipophilic contaminant ratio. Because a number
of the chemicals had extreme values for blood levels
the geometric mean blood level value was used. The
median concentration of each of the chemicals was
then summed to calculate the median total mass of
chemicals among this population. The relative contri-
bution (by mass) of each specific chemical was then
calculated as the percent (by mass) of each chemical to
the total chemical load (by mass). Chemicals that con-
tributed more than 1% to the total mass were selected
for inclusion in the mixture. This percent mass value
for lipophilic chemicals then represented the percent
by mass of each chemical to the overall chemical mix-
ture and served as the basis for preparing the mixture.
The final proportionate mass of each chemical in the
final mixture then represented the proportionate mass
of each chemical found in human blood in μg/l. Once
the relative proportions of the lipophilic contaminant
was established, the concentration of MeHg was calcu-
lated on the basis of the ratio of MeHg to total PCB
shown in Arctic maternal blood. The final MeHg:PCB
ratio was 1.8:1 in the complete mixture and accounting
for 38% of the total mixture mass. Finally, prior to any
dosing, the mixture was analyzed to verify the chemical
concentration both internally and in an independent
laboratory (Wellington laboratories, Guelph, Ontario).
In both cases, these analyses confirmed the concentra-
tion in the final chemical mixture.
All of the chemicals had a purity > 99% with the
exception of PCB187, which had a certified purity of
97%, and toxaphene (Cerilliant, Round Rock, Tx) and
methylmercury (Aldrich Chemical Co, Milwaukee, WI),
which were of technical grade. Oxychlordane was a gen-
erous gift from Julie Fillion of the Pest Management
Regulatory Agency (Ottawa, ON, Canada). Sources for
other chemicals were as follows: PCB 99 and 183
(AccuStandard, New Haven, CT); p,p’-DDE (Sigma-
Aldrich, St Louis, MO), p,p’-DDT (Riedel-de Haën,
Sigma-Aldrich Laborchemikalien, Seelze, Germany), and
hexachlorobenzene (Fluka, Steinhein, Switzerland). All
other chemicals were purchased from Cerilliant (Round
Rock, Tx). Separate stock solutions of the PCBs, the OC
pesticides, and the MeHg in corn oil were initially pre-
pared. For the OC stock solutions, the OC chemicals
(total mass 556.84 mg) were dissolved in 40 ml of spec-
trophotometric grade, inhibitor free diethyl ether (99.9%,
Sigma-Aldrich), and then added drop-wise to 60 ml of
Mazola corn oil while stirring, and the corn oil was con-
tinually stirred for a further 30 minutes in a fume hood.
This solution was then evenly separated into six 20 ml
scintillation vials and the diethyl ether was removed
using a Savant Automatic Environment Speedvac
(Model AES 2000). The complete removal of the diethyl
ether was confirmed by weighing every two hours until
the difference of weights of two continuous weighing
was within 5 mg for each vial. The OC stock was then
quantitatively transferred to a 250 ml amber bottle with
fresh corn oil rinsing the vials and well mixed (final
concentration = 5.273 mg/ml corn oil). The PCB stock
solution was prepared in a similar way. The PCB conge-
ners (total mass 843.14 mg) were dissolved in 25 ml of
diethyl ether, and added to 80 ml Mazola corn oil. The
PCB corn oil solution was evenly separated into eight 20
ml scintillation vials and the diethyl ether was removed.
This PCB corn oil solution was then quantitatively
transferred to a 250 ml amber bottle and the final con-
centration of PCB in the corn oil is 5.954 mg/ml. MeHg
was prepared by dissolving 1.5167 g MeHg into 100 ml
of Mazola corn oil by stirring and intermittent ultra-
sound sonication over two days and quantitatively trans-
ferred to a 250 ml amber bottle and the concentration
of MeHg in the corn oil is 12.11 mg/ml. The dosing
solution for full mixture (5.0 mg/ml) was prepared by
combining 84.1 g of the OC stock solution, 37.5 g of
the PCB stock solution, 33.8 g of the MeHg stock solu-
tion and 59.1 g of corn oil and then diluting this by
adding 1 ml of this solution into 99 ml of corn oil. The
dosing solution for the PCB+MeHg solution (1.89 mg/
ml) was prepared by adding 37.5 g of the PCB stock
solution with 33.8 g of the MeHg stock solution and
142.8 g of corn oil and then diluting this by adding 1 ml
of this solution into 99 ml of corn oil. The dosing
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prepared by mixing 37.5 g of the PCB stock solution
with 172.2 g of corn oil and then diluting this by adding
1 ml of this solution into 99 ml of corn oil. The dosing
solution for the MeHg only solution (1.89 mg/ml) was
prepared by mixing 33.8 g of the MeHg stock solution
with 180.9 g of corn oil and then diluting this by adding
1 ml of this solution into 99 ml of corn oil. The concen-
tration of each chemical in each dosing solutions for is
shown in Table 1.
Brain dissection procedures
Following decapitation, rat brains were placed in a stain-
less steel brain blocker and a series of coronal sections
(1.0 mm thick) were produced. As already indicated we
chose to focus on the hypothalamus given that this
region has higher than normal levels of most cytokines
and the fact that most research indicates a critical role
for hypothalamic functioning in cytokine induced neuro-
nal alterations. The hypothalamus was then rapidly dis-
sected from the two coronal sections containing this
structure. Brain tissue was t h e nf l a s hf r o z e ni nl i q u i d
n i t r o g e na n ds t o r e da t- 8 0 ° Cuntil assayed. Thereafter,
brain tissue was homogenized and centrifuged at 6000
RPM for 10 min at 4°C, after which 50 μlo ft h es u p e r -
natant was collected for use in the Luminex analysis.
Multiplex Luminex determination of brain cytokine levels
The Luminex 100 (Luminex Corp., Austin, TX) is a sus-
pension-based bead array system that can detect up to
100 different analytes in a single 50 μl sample. Sets of
microspheres (5.6 μm beads) are internally dyed with
different ratios of fluorophores, each conjugated to a dif-
ferent capture probe (cytokine specific antibody). Fol-
lowing incubation, a classification laser identifies the
particular cytokine bound and a second reporter laser
quantifies the signal present. We utilized a custom mul-
tiple cytokine detection kit (Beadlyte Mouse Multi-
Cytokine Detection System, Upstate Cell Signalling
Solutions) to detect levels of IL-1b, IL-2, IL-4, IL-6, IL-
10, IL-12, IFN-g and TNF-a.
To prepare standards for Luminex analysis, 5000 pg of
Multi-Cytokine 2 standard was re-suspended in 1 ml
serum diluent and vortexed at a medium speed for 15 s,
following which serial dilutions were prepared. After 25
μl of Beadlyte Cytokine Assay Buffer was added to the
wells, plates were vortexed and a vacuum manifold
applied to remove excess liquid. Subsequently, 25 μlo f
s e r u md i l u e n ta n d2 5μl of sample were added to each
well. Following 20 min incubation on a shaker, the anti-
mouse multi-cytokine beads were vortexed, sonicated
and 25 μl of the bead solution added to the wells. After
a brief vortex, plates were then incubated overnight at
4°C. Thereafter, samples were re-suspended in 50 μlo f
Beadlyte Cytokine Assay Buffer and the vortex and
washing procedures repeated. Finally, 25 μlo fb i o t i n
conjugated cytokine beads were added for 90 min incu-
bation in the dark. Just prior to the end of the incuba-
tion period, the Beadlyte Streptavidin-PE was diluted
(1:25) and 25 μl was added to each well for the final 30
min incubation. The assay was then halted using 25 μl
of Beadlyte Stop Solution. Filter plates were then read in
a Luminex 100 instrument, fitted with a five-parameter
logistic regression curve using QT Masterplex software
(MiraiBio, Hitachi, CA) [42,30].
Statistical Analyses
All data were analyzed using ANOVA followed by Tukey’s
post hoc comparisons where appropriate. In effect, we
assessed whether 1. perinatal treatment with PCBs or
MeHg induced cytokine changes, relative to vehicle (Veh)
only treated group, and 2. whether the combined PCB +
MeHg or full Arctic chemical mixture promoted further
cytokine elevations greater than their individual effects. In
our second study, female litter-mates received the same
treatments except that all rats were administered LPS on
PND 208-212 in order to determine if the cytokine
response to LPS was modified by previous perinatal expo-
sure to the chemicals. Hence, the first study examined
basal cytokine levels at PND 145-147, while the second
study used litter-mates that were administered LPS 90
min before sacrifice at PND 208-212. Data were evaluated
using a StatView (version 6.0) statistical software package
available from the SAS Institute, Inc.
Results
The cytokines IL-2 and IL-4 were below detection levels
for most animals and likewise, substantial variability of
IFN-g precluded detection of any reliable between group
differences. Hence, these cytokines are not further
discussed.
T h eA N O V Af o rh y p o t h a l a m i cI L - 1 bl e v e l sj u s t
missed significance with regards to the effects of perina-
tal chemical exposure F (4, 33) = 2. 52, p = 0.07).
Indeed, as shown in Figure 1a there was a definite trend
towards elevated levels of the cytokine among rats that
received the PCB + MeHg or full Arctic mixture treat-
ments. Although IL-1b levels were (not surprisingly)
appreciably greater overall in the second study that
involved adult LPS administration (compared to non-
LPS treated rats of study 1), no significant differences
were apparent with regards to the Arctic chemical treat-
ments (see Figure 1b). Although variability within the
treatment groups prevented finding statistical signifi-
cance, it is important to underscore that the IL-1b levels
in the PCB + LPS and full mixture + LPS treatment
conditions were elevated by ~2.5 times that of the vehi-
cle + LPS group.
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cantly affect hypothalamic IL-6 levels F (4, 33) = 2. 79,
p < 0.05. Indeed, the follow up comparisons revealed
that PCB alone, as well as the full mixture of chemicals
increased IL-6 levels above that of rats treated with
vehicle or MeHg (p < 0.05; see Figure 2a). In contrast,
no significant differences in hypothalamic IL-6 levels
were evident among the perinatal chemical treatment
groups that received an LPS injection in adulthood
(Figure 2b).
Perinatal treatment with the Arctic chemicals pro-
voked significant differences in hypothalamic IL-10
levels F (4, 33) = 2.32, p < 0.05. Interestingly, only rats
that received the full Arctic chemical mixture displayed
hypothalamic IL-10 levels that exceeded that of vehicle
treated animals, as well as those exposed to MeHg or
MeHg + PCB (p < 0.05; Figure 3a). Once again, no sig-
nificant differences were observed among the chemical
treated groups that were administered LPS in adulthood
(P > 0.05; see Figure 3b).
No significant differences in hypothalamic IL-12 or
TNF-a levels were evident between the perinatal chemi-
cal treatments. However, it is worthwhile to note the
substantial trends towards increased levels of these cyto-
kines as a function of combined administration of the
Arctic chemicals. In particular, IL-12 and TNF-a levels
were approximately 40% higher in rats exposed to the
full Arctic mixture, relative to those that received vehi-
cle (see Figures 4a &5a). Thus, we conducted post hoc
analyses based on our hypothesis that these pro-inflam-
matory cytokine would be elevated by the early life che-
mical treatments. In this regard, rats that received the
full mixture perinatally displayed significantly increased
IL-12 and TNF-a concentrations, relative to vehicle
treated controls (p < 0.05). Again, although LPS treated
rats had greater overall IL-12 and TNF-a levels com-
pared to those that did not receive the endotoxin, there
were no detectable differences between perinatal treat-
ment groups (Figures 4b &5b).
Discussion
Apart from the influence of genetic differences, certain
populations of individuals might be at higher risk of
CNS disturbances owing to increased exposure asso-
ciated with food intake patterns related to lifestyle. In
this regard, Arctic populations have higher than average
(compared populations living in Southern Canadian
locations) concentrations of several toxins (including
Figure 1 Hypothalamic IL-1b changes in offspring at PND 145-
147 (A) and in animals at PND 208-212 that received LPS
immediately before sacrifice (B). All animals were exposed to the
chemical mixture, PCBs, MeHg or MeHg+PCBs during gestation and
lactation.. n = 8-10
Figure 2 Hypothalamic IL-6 changes at PND 145-147 (A) and in
animals at PND 208-212 that received LPS immediately before
sacrifice (B). All animals were exposed to the chemical mixture,
PCBs, MeHg or MeHg+PCBs during gestation and lactation.. n = 8-
10. * p < 0.05, relative to Veh or Hg treated groups.
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diets consisting of wildlife that bioaccumulate these
environmental chemicals. The high levels of metals,
PCBs, and pesticides (e.g. DDT) consumed from fish
and other species of northern Canada [16-18] would be
expected to readily penetrate multiple organs and even-
tually enter the brain.
We presently report that in utero + gestational expo-
sure to a mixture of chemical contaminants (MeHg, pes-
ticides, PCBs), based on blood contaminant profiles in
Northern Canadian Inuit Arctic mothers, produced long
term elevations of several cytokines within the hypothala-
mus of female rats. These effects on hypothalamic brain
cytokines were evident in adulthood long after dosing
ceased (about 120 days after dosing) and were observed
when toxin exposure produced blood levels in rat dams
near those of humans. Indeed, analysis of tissue residue
data from previous studies using identical dosing proce-
dures showed that blood levels in rat mothers were com-
parable to those of Arctic human mothers [27]. Yet, one
should still exercise caution when extrapolating between
human and rat samples. While early life exposure to
MeHg had little impact on cytokines in the present
study, the PCBs and the full mixture (containing PCBs,
OCs and MeHg) both elevated basal cytokine levels when
assessed at five months of age. Although systemic expo-
sure to LPS at five months of age increased most
hypothalamic cytokines, prior developmental exposure to
the contaminants did not alter the impact of LPS on
adult cytokine levels. Thus, developmental exposure to
realistic levels of environmental chemicals provoked long-
term inflammatory cytokine elevations within the brain
but did not sensitize animals to the impact of endotoxin
exposure at adulthood.
These findings are consistent with the evidence indicat-
ing that exposure to environmental toxins during neuro-
development can influence central nervous system (CNS)
functioning long after exposure has occurred. For
instance, gestational exposure to PCBs, mercury, lead,
and organic pollutants has been associated with later
cognitive disturbances in infants and children and may
contribute to disorders of attention and activity [9,43-45].
Yet, such cognitive effects are generally mediated by
hippocampal and cortical brain regions, whereas hypotha-
lamic brain changes (as observed in the present investiga-
tion) are typically associated with stress responses and
hormonal output. Indeed, a plethora of data indicates
that psychological and immunological (particularly LPS)
stressors promote marked hypothalamic neurochemical
Figure 3 Hypothalamic IL-10 changes at PND 145-147 (A) and
in animals at PND 208-212 that received LPS immediately
before sacrifice (B). All animals were exposed to the chemical
mixture, PCBs, MeHg or MeHg+PCBs during gestation and lactation.
n = 8-10. * p < 0.05, relative to Veh and PCB + Hg treated groups.
Figure 4 Hypothalamic IL-12 changes at PND 145-147 (A) and
in animals at PND 208-212 that received LPS immediately
before sacrifice (B). All animals were exposed to the chemical
mixture, PCBs, MeHg or MeHg+PCBs during gestation and lactation.
n = 8-10. * p < 0.05, relative to Veh treated group.
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fever, piloerection, ptosis, curled body posture) or depres-
sive-like symptoms, such as anhedonia [38,40,46-49].
Similarly, we and others have reported that a range of
stressful conditions (particularly psychosocial stressors
stemming from changes in housing conditions), cytokines
(including IL-1b, TNF-a and IFN-a) and immune agents
that mimic bacterial or viral infections (LPS and poly I:C,
respectively) increase hypothalamic cytokine expression
and promote microglial-dependent neuroinflammatory
activity [39,50-53].
Although scant data exists regarding the impact of che-
mical toxins and hypothalamic functioning, one recent
report did indicate that the pesticide, dieldrin, increased
hypothalamic expression of an array of genes that are
known to be responsible for oxidative functions and cell
survival [54]. Similarly, MeHg was found to reduce
hypothalamic dopamine levels and induce anxiety-like
effects in exposed fish [55]. Hypothalamic and limbic
brain circuits, along with a shift towards increased pro-
duction of pro-inflammatory Th1 cytokines, were even
posited to be responsible for the sickness symptoms pro-
voked by smells associated with previous chemical toxin
exposure [56].
Further rationale for focusing upon the hypothalamus
(besides it being a key stress integrative brain region
that is known to express a higher level of cytokines than
most brain regions), stems from the substantial evidence
showing that several pesticides and PCBs have well
known endocrine disruption effects and have been
reported to affect HPA and immune functioning. For
instance, systemic administration of the PCB mixture,
Aroclor 1248, altered glucocorticoid levels and the mito-
genic response of peripheral immune cells [57]. When
an alternate PCB mixture (Aroclor 1254) was orally
administered to female monkeys, dose-dependent altera-
tions of T cell activity and antibody production were
observed [58,59]. Intriguingly, perinatal exposure to PCB
congers 126 and 153 (as in the present study) appeared
to sensitize the HPA axis, such that a much greater and
prolonged cortisol response was evident with mild stress
application at nine months of age [60]. Similar to the
PCBs, several different classes of pesticides were
reported to affect HPA functioning in a number of dif-
ferent species, including male and female rats, as well as
bears and fish [61-64]. Although scant data exist for
MeHg, one recent study did report that Beluga sturgeon
fed MeHg rich diets displayed elevated cortisol and glu-
cose levels [65].
While the blood levels of contaminant in these ani-
mals were not available, we have conducted previous
studies using identical dosing methodology and have
shown that this dose of the mixture produces blood
levels of PCB and OC pesticides in rat dams that are
comparable to maternal blood levels in Canadian Arctic
human population [27] Table 1. Other studies using the
same mixture and dosing regimen has shown that PCBs
and MeHg can both alter cerebellar gene expression
patterns [66,67]. Taken together with the present results,
t h ea v a i l a b l ee v i d e n c es u g g e sts that, at exposure levels
relevant to human populations, the chemical mixture
likely affects neurodevelopmental processes and has
long-term consequences upon cytokines that are known
to fundamentally shape neuroinflammatory functioning.
Gestational and lactational transfer of environmental
toxins would be expected to place the developing fetus
or young offspring at risk. These would be especially
evident during in utero and perinatal stages, when neu-
ronal migration and synaptic pruning are occurring,
neurons are especially sensitive to perturbations caused
by environmental agents. At the same time, biological
detoxification systems involved in metabolism and clear-
ance of toxic substances are not fully developed in
fetuses, infants and young children [68,69]. Indeed, it is
likely of particular importance that toxin exposure in
the present investigation occurred during times of rapid
neural development, when the blood-brain-barrier (BBB)
is not fully functional and the brain is exquisitely
Figure 5 Hypothalamic TNF-a changes at PND 145-147 (A) and
in animals at PND 208-212 that received LPS immediately
before sacrifice (B). All animals were exposed to the chemical
mixture, PCBs, MeHg or MeHg+PCBs during gestation and lactation.
n = 8-10. * p < 0.05, relative to Veh treated group.
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migration and differentiation, as well as synapse forma-
tion [70,71]. Some of these same chemicals, including
MeHg and the various pesticides, can cause deficits in
BBB functioning, evident as a long term increased per-
meability [72-75]. Hence, the protracted hypothalamic
cytokine changes presently observed could conceivably
have stemmed from deficiencies in BBB functioning
induced by the Arctic chemicals, resulting in enhanced
infiltration of peripheral immune cells. Yet, it is impor-
tant to consider that some aspects of the hypothalamus
(median eminence) actually lack a fully functional BBB
and may facilitate penetration of the toxins. Besides any
effects of peripheral immune cells, it seems likely that
the chemical insults could have directly affected central
glial activity, as has been observed following bacterial
endotoxin challenge [76], thereby promoting local cyto-
kine production [77].
One of the primary mechanisms through which toxins
may promote CNS pathology is by inducing inflamma-
tory immune factors. Indeed, neurodegeneration and
CNS pathology in general, often have a prominent neu-
roinflammatory component, which is typically character-
ized by excessive microglial activation and accumulation
of pro-inflammatory cytokines and oxidative factors
[35,78-80]. Similarly, pesticides have been reported to
increase superoxide production from circulating neutro-
phils, as well as promote cortical astrocyte expression
and induce the expression of the pro-inflammatory cyto-
kines IL-6, IL-8 and IFN-g [66,80-82]. Our own work
has also shown that the acute adult exposure to the pes-
ticide, paraquat, provoked neuroinflammatory changes,
including an elevation of microglial cell reactivity that
was closely tied to the neuronal loss provoked by the
pesticide [30]. The current results further show that
exposure to a combination of environmental pollutants
containing OCs, when given at realistic concentration/
ratios, increase hypothalamic IL-6 and IL-10, and to a
certain degree, IL-1b, IL-12 and TNF-a concentrations.
The lack of statistically significant differences between
the Arctic chemical treated groups that received LPS in
adulthood was somewhat surprising. Indeed, it was
reported that early life exposure to LPS promoted an
enhanced neurodegenerative effect, coupled with
increased central TNF-a levels, upon exposure to the
pesticide, rotenone, later in life [83]. However, the fail-
ure to presently detect cytokine differences in response
to the acute adult LPS challenge likely stems from a
ceiling effect. In fact, the endotoxin did generally aug-
ment most cytokines in all groups (relative to the endo-
toxin naive rats of the initial study) and such an effect
might have made it especially difficult to detect any
subtle effects of the early life chemical treatments.
Along these lines, there was a definite trend of increased
hypothalamic IL-1b levels in the PCB and full Arctic
mixture perinatally treated mice that received LPS in
adulthood. The variability in the response to LPS appar-
ent in these mice suggests that some animals were
“responders” and some “non-responders” to the early
life chemical priming. Future studies aimed at better
characterizing this effect would benefit from assessing
the impact of a variety of LPS doses. Along with not
having a dose-response for LPS, another caveat of this
second study is the lack of a “pure” control group
(owing to the availability of animals) that did not receive
LPS.
The cytokine changes observed within the hypothala-
mus could have substantial behavioral implications. For
instance, IL-1b, IL-6 and TNF-a have well documented
sickness effects (e.g. ptosis, piloerection, curled body
posture) that are related to hypothalamic neurochemical
activity [37,84,85]. These inflammatory cytokines have
also been implicated in a number of clinical conditions
involving a primary component of fatigue or malaise,
including chronic fatigue syndrome and multiple chemi-
cal sensitivity [86,87]. In fact, disturbances of hypothala-
mic neuroendocrine activity and elevations of brain
cytokines which are evident following challenge with the
viral mimic, poly I:C (double stranded RNA), have been
proposed to be common mechanisms leading to chronic
fatigue and sickness [88,89]. Interestingly, pesticide
exposure has likewise been implicated in multiple che-
mical sensitivity syndromes and general sickness symp-
toms [90,91]. We have also reported that the pesticide,
paraquat, induced behavioral changes reminiscent of
Parkinson’s disease and depression [34]. In effect, it is
possible that the present hypothalamic cytokine changes
induced by early life chemical treatments could have
important consequences for behavioral and neuroendo-
crine functioning.
It is unclear whether the enduring CNS cytokine
alterations provoked by the perinatal chemical treat-
ments (observed months after exposure) stemmed from
cumulative/progressive time-dependent effects or a long
lasting more acute impact of these treatments. In any
case, it is interesting to note that several studies have
indicated that stressor exposure had neurochemical
effects that increased with the passage of time [92,93].
Our own work likewise demonstrated that the cytokine,
TNF-a, time-dependently, sensitized CNS processes,
such that re-exposure to the cytokine one month follow-
ing a previous single injection induced greatly augmen-
ted behavioral (sickness symptoms), corticoid and
central monoamine (NE within the hypothalamus)
changes [38,94]. Regardless of the mechanisms responsi-
ble for the central cytokine variations, these immuno-
transmitters are ultimately able to act upon their
receptors (found predominately on glial cells and to a
Hayley et al. Environmental Health 2011, 10:65
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STAT (IL-6, IL-10 and IL-12) and NFkB (IL-1b, TNF-a)
signaling pathways. While these signaling pathways
mediate the anti-tumor and immunological functions of
cytokines in the periphery, increasing evidence has also
indicated an important role in a range of neurological
conditions ranging from depression to Parkinson’sa n d
Alzheimer’s disease [95-97].
Conclusions
The present investigation revealed that administration of
a mixture of environmental toxins at environmentally-
relevant doses induced long term elevations of cytokine
protein concentrations within the hypothalamus. This is
important in light of the fact that most experimental
studies to date have involved administration of high
levels of single chemicals that do not necessarily reflect
the actual human exposures or human body burden.
Indeed, it might be deceiving to evaluate toxins in isola-
tion given that certain combinations of heavy metals
and pesticides were found synergistically provoke
numerous histopathological consequences (e.g. confor-
mational changes in alpha-synuclein) and oxidative
stress induced neurodegeneration [31]. Moreover, the
current cytokine changes were evident in adult rats fol-
lowing indirect exposure (through placental transfer or
from breast milk) during neurodevelopmentally sensitive
times (pre- and perinatal exposure). Given the substan-
tial data suggesting that cytokines markedly influence
neurotransmission and neuronal survival, the present
findings support an involvement of environmental con-
taminants in the development of neurological or psy-
chiatric disturbances.
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